Literature DB >> 2921374

Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis.

A J van Winkelhoff1, J P Rodenburg, R J Goené, F Abbas, E G Winkel, J de Graaff.   

Abstract

The potential use of an adjunctive therapy of metronidazole plus amoxycillin for the subgingival elimination of Actinobacillus actinomycetemcomitans in periodontitis patients was investigated. 22 patients participated in this study, 11 with localized juvenile periodontitis (LJP) and 11 with rapidly progressive periodontitis (RPP). 14 patients had received periodontal treatment in the past. All patients were subgingivally infected with A. actinomycetemcomitans. After mechanical subgingival debridement in combination with the antibiotic treatment, elimination of A. actinomycetemcomitans was achieved in all patients but one. With this one exception, clinical improvements were observed in all patients, resulting in reduced pocket probing depths as well as in a significant reduction in bleeding on probing. Re-examination of 16 patients after 9-11 months revealed that A. actinomycetemcomitans was still undetectable and further clinical improvement was observed. It was concluded that the combination of metronidazole plus amoxycillin is a valuable adjunct to mechanical therapy in A. actinomycetemcomitans associated periodontal infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921374     DOI: 10.1111/j.1600-051x.1989.tb01626.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  46 in total

1.  Identification and molecular analysis of rough-colony-specific outer membrane proteins of Actinobacillus actinomycetemcomitans.

Authors:  E M Haase; J L Zmuda; F A Scannapieco
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

2.  Intraoral dissemination of treponemes after periodontal therapy.

Authors:  Benjamin Ehmke; Thomas Beikler; Birgit Riep; Thomas Flemmig; Ulf Göbel; Annette Moter
Journal:  Clin Oral Investig       Date:  2004-06-23       Impact factor: 3.573

3.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

5.  Clinical results after nonsurgical therapy in aggressive and chronic periodontitis.

Authors:  Susanne Scharf; Martin Wohlfeil; Yasemin Siegelin; Beate Schacher; Bettina Dannewitz; Peter Eickholz
Journal:  Clin Oral Investig       Date:  2013-06-10       Impact factor: 3.573

Review 6.  Non-surgical periodontal therapy supplemented with systemically administered azithromycin: a systematic review of RCTs.

Authors:  Sabrina L Buset; Nicola U Zitzmann; Roland Weiger; Clemens Walter
Journal:  Clin Oral Investig       Date:  2015-06-12       Impact factor: 3.573

Review 7.  Lessons learned and unlearned in periodontal microbiology.

Authors:  Ricardo Teles; Flavia Teles; Jorge Frias-Lopez; Bruce Paster; Anne Haffajee
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

8.  The role of Actinobacillus actinomycetemcomitans in periodontal disease.

Authors:  J de Graaff; A J van Winkelhoff; R J Goené
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

9.  Subgingival plaque sampling after combined mechanical and antibiotic nonsurgical periodontal therapy.

Authors:  Tatjana Ramich; Beate Schacher; Susanne Scharf; Lasse Röllke; Rita Arndt; Peter Eickholz; Katrin Nickles
Journal:  Clin Oral Investig       Date:  2014-02-20       Impact factor: 3.573

10.  Use of platelet-rich plasma in periodontal surgery--a prospective randomised double blind clinical trial.

Authors:  L Harnack; R H Boedeker; I Kurtulus; S Boehm; J Gonzales; J Meyle
Journal:  Clin Oral Investig       Date:  2008-09-03       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.